Dr. Rajeev Grover, M.D.
What this data tells you about Dr. Grover
Dr. Rajeev Grover is a cardiovascular disease in Houston, TX, with 20 years in practice. Based on federal Medicare data, Dr. Grover performed 4,464 Medicare services across 1,608 unique beneficiaries.
Between the years covered by Open Payments, Dr. Grover received a total of $5,134 from 36 pharmaceutical and/or device companies across 266 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Grover is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote patient monitoring management, 20 min/month | 814 | $39 | $140 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 806 | $32 | $160 |
| Remote patient monitoring device, 30 days | 701 | $40 | $120 |
| Office visit, established patient (30-39 min) | 660 | $101 | $330 |
| Electrocardiogram (EKG), 12-lead | 398 | $11 | $52 |
| Echocardiogram, transthoracic | 238 | $158 | $704 |
| Regadenoson injection (Lexiscan) for heart stress test | 180 | $45 | $76 |
| Hospital follow-up visit, high complexity | 115 | $98 | $322 |
| Ultrasound of both sides of head and neck blood flow | 94 | $157 | $623 |
| Office visit, established patient, complex (40-54 min) | 75 | $141 | $445 |
| Office visit, established patient (20-29 min) | 60 | $72 | $224 |
| Programming of dual lead pacemaker system | 48 | $66 | $180 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 46 | $767 | $978 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 45 | $1,981 | $4,786 |
| Nuclear medicine study of heart muscle blood flow by pet | 45 | $149 | $360 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 45 | $58 | $200 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 24 | $16 | $40 |
| Initial hospital admission, high complexity | 20 | $143 | $625 |
| New patient office visit (45-59 min) | 17 | $134 | $504 |
| Ultrasound study of arm and leg arteries | 11 | $68 | $273 |
| Ultrasound of leg arteries or artery grafts | 11 | $196 | $797 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 11 | $157 | $606 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
4.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Grover is a clinical cardiology specialist, with above-average Medicare volume (top 21% in TX), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Grover experienced with remote patient monitoring management, 20 min/month?
Does Dr. Grover receive payments from pharmaceutical companies?
How do Dr. Grover's costs compare to other cardiovascular diseases in Houston?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology